Archive for July 26th, 2010

Jul 26 2010

Euthymics Bioscience, Inc. Closes $24 Million Series A Financing and Completes Acquisition of DOV Pharmaceutical

Posted by admin in Ecstasy Addictions

More info…
CAMBRIDGE, Mass.—-Euthymics Bioscience, Inc., a clinical-stage company developing next-generation antidepressants, today announced the completion of a Series A financing — led by Novartis Venture Funds and Venture Investors for a total investment commitment of $24 million in milestone-conditioned tranches.

ecstasy and addiction

Share and Enjoy:
  • Digg
  • Bumpzee
  • del.icio.us
  • Facebook
  • Furl
  • Mixx
  • NewsVine
  • Reddit
  • StumbleUpon
  • YahooMyWeb
  • Google

Comments No Comments »